Kymera Therapeutics
KYMR
KYMR
210 hedge funds and large institutions have $4.58B invested in Kymera Therapeutics in 2025 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 210 → 210 (0)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
7.9% less ownership
Funds ownership: 121.01% → 113.11% (-7.9%)
Holders
210
Holding in Top 10
12
Calls
$8.81M
Puts
$3.3M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$32M | |
| 3 | +$31.6M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$29.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$26.3M |
Top Sellers
| 1 | -$99.7M | |
| 2 | -$35.1M | |
| 3 | -$27M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$14.2M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$12M |
